Page 2 - Nasdaq Npce News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq npce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Npce Today - Breaking & Trending Today

NeuroPace, Inc. (NASDAQ:NPCE) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the five research firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month target […] ....

United States , Martha Morrell , Nantahala Capital Management , Wells Fargo Company , Cantor Fitzgerald , Neuropace Inc , Kent Lake Capital , Millennium Management , Securities Exchange Commission , Morgan Stanley , Jpmorgan Chase Co , Get Free Report , Street Capital , Wells Fargo , Exchange Commission , Lake Capital , Capital Management , Get Free , Neuropace Daily , Nasdaq Npce ,

NeuroPace, Inc. (NASDAQ:NPCE) Insider Martha Morrell Sells 827 Shares

NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) insider Martha Morrell sold 827 shares of the firm’s stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $15.03, for a total transaction of $12,429.81. Following the sale, the insider now owns 109,200 shares of the company’s stock, valued at […] ....

United States , Martha Morrell , Wells Fargo Company , Morgan Stanley , Securities Exchange Commission , Citigroup Inc , Kent Lake Capital , Vanguard Group Inc , Cantor Fitzgerald , Jpmorgan Chase Co , Neuropace Inc , Neuropace Company Profile , Get Free Report , Exchange Commission , Space Trading Down , Street Capital , Lake Capital , Neuropace Daily , Nasdaq Npce , Insider Trading , Nsider Trades ,

NeuroPace (NASDAQ:NPCE) Price Target Increased to $9.00 by Analysts at JPMorgan Chase & Co.

NeuroPace (NASDAQ:NPCE – Free Report) had its price target lifted by JPMorgan Chase & Co. from $6.00 to $9.00 in a research note released on Tuesday, Benzinga reports. They currently have an overweight rating on the stock. NPCE has been the topic of several other research reports. Morgan Stanley raised shares of NeuroPace from an […] ....

United States , Neuropace Inc , Citigroup Inc , Geode Capital Management , Wells Fargo Company , Barclays Plc , Orbimed Advisors Llc , Jpmorgan Chase Co , Renaissance Technologies , Susquehanna International Group , Morgan Stanley , Free Report , Moderate Buy , Get Free Report , International Group , Capital Management , Neuropace Daily , Nasdaq Npce , Boost Price Target , Jpmorgan Chase Co ,

NeuroPace to Report Third Quarter 2023 Financial Results on

MOUNTAIN VIEW, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on. ....

Jeremy Feffer , Exchange Commission , Neuropace Inc , Monday November , Mountain View , Financial Condition , Quarterly Report , Nasdaq Npce ,

Wells Fargo & Company Boosts NeuroPace (NASDAQ:NPCE) Price Target to $9.00

NeuroPace (NASDAQ:NPCE – Get Free Report) had its target price increased by analysts at Wells Fargo & Company from $6.00 to $9.00 in a report issued on Wednesday, FlyOnTheWall reports. Wells Fargo & Company‘s price target would suggest a potential upside of 7.02% from the company’s previous close. Separately, Morgan Stanley upgraded NeuroPace from an […] ....

United States , Citadel Advisors , Neuropace Company Profile , Blackrock Inc , Wells Fargo Company , Morgan Stanley , Susquehanna International Group , Neuropace Inc , Renaissance Technologies , Sg Americas Securities , Get Free Report , Wells Fargo , Space Stock Down , International Group , Neuropace Daily , Nasdaq Npce , Boost Price Target ,